Martin Wilson

Insider Reports History

Entity
Individual
Location
C/O Teligent, Inc., 105 Lincoln Avenue, Buena, NJ
Signature
/s/ Martin Louis Wilson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Martin Wilson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ROCKET PHARMACEUTICALS, INC. General Counsel Common Stock 64.7K $1.2M $18.50 Aug 16, 2024 Direct
ROCKET PHARMACEUTICALS, INC. General Counsel Stock Option (Right to Buy) 49.1K $684K $13.93 Feb 16, 2024 Direct
ROCKET PHARMACEUTICALS, INC. General Counsel Restricted Stock Units 19.4K $527K $27.20 Feb 14, 2024 Direct

Insider Reports Filed by Martin Wilson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RCKT ROCKET PHARMACEUTICALS, INC. Aug 16, 2024 1 -$19K 4 Aug 20, 2024 General Counsel
RCKT ROCKET PHARMACEUTICALS, INC. May 14, 2024 7 -$24.5K 4 May 20, 2024 General Counsel
RCKT ROCKET PHARMACEUTICALS, INC. Feb 29, 2024 1 -$120K 4 Mar 4, 2024 General Counsel
RCKT ROCKET PHARMACEUTICALS, INC. Feb 16, 2024 3 -$107K 4 Feb 21, 2024 General Counsel
RCKT ROCKET PHARMACEUTICALS, INC. Feb 14, 2024 2 $0 4 Feb 16, 2024 General Counsel
RCKT ROCKET PHARMACEUTICALS, INC. Feb 14, 2023 2 $0 4 Feb 16, 2023 General Counsel
RCKT ROCKET PHARMACEUTICALS, INC. Aug 12, 2022 2 $0 4 Aug 16, 2022 General Counsel
RCKT ROCKET PHARMACEUTICALS, INC. Dec 6, 2021 1 $0 4 Dec 8, 2021 General Counsel
RCKT ROCKET PHARMACEUTICALS, INC. Dec 6, 2021 0 $0 3 Dec 8, 2021 General Counsel